Level Bio AB (FRA:4MB) Net Margin %: -1.92% (As of Mar. 2026)


FRA:4MB Level Bio AB FRA:4MB
23 GF Score
Price €0.01
! 4 Warning Signs
View Full Analysis

What is Level Bio AB Net Margin %?

Level Bio AB FRA:4MB +8.00% 23 Net Margin % is -1.92% as of Mar. 2026. GuruFocus rates FRA:4MB with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Level Bio AB ranks worse than 55.88% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Level Bio AB's Net Income for the three months ended in Mar. 2026 was €-0.02 Mil. Level Bio AB's Revenue for the three months ended in Mar. 2026 was €0.84 Mil. Therefore, Level Bio AB's net margin for the quarter that ended in Mar. 2026 was -1.92%.

The historical rank and industry rank for Level Bio AB's Net Margin % or its related term are showing as below:

FRA:4MB' s Net Margin % Range Over the Past 10 Years
Min: -36.31   Med: -6.12   Max: 11.73
Current: -8.57

FRA:4MB's Net Margin % is ranked worse than
55.88% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.56 vs FRA:4MB: -8.57

Level Bio AB  (FRA:4MB) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Level Bio AB Net Margin % Related Terms

Level Bio AB Net Margin % Historical Data

* Premium members only.

The historical data trend for Level Bio AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Bio AB Net Margin % Chart

Level Bio AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.73 -6.47 -36.31 -31.35 -10.93

Level Bio AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.66 -17.21 -2.44 -11.55 -1.92

FRA:4MB vs TMO, DHR, IDXX: Net Margin % Comparison

For the Diagnostics & Research subindustry, Level Bio AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Level Bio AB Net Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where Level Bio AB's Net Margin % falls into.


FRA:4MB
23GF Score
Level Bio AB FRA:4MB
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Level Bio AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Level Bio AB's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.325/2.974
=-10.93 %

Level Bio AB's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.016/0.835
=-1.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -1.92% mean?
Level Bio AB (FRA:4MB) has a Net Margin % of -1.92% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Level Bio AB and its competitors. According to the industry distribution chart, Level Bio AB ranks #114 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 55.9%.
Is Level Bio AB's Net Margin % too high?
Level Bio AB's current Net Margin % is -1.92%. Based on the distribution chart, Level Bio AB ranks #114 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Level Bio AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Level Bio AB's Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Level Bio AB ranks #114 out of 204 companies for Net Margin %. This places Level Bio AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Level Bio AB and its competitors. Level Bio AB's current Net Margin % is -1.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Bio AB stock overvalued right now?
Level Bio AB (FRA:4MB) has a current Net Margin % of -1.92%. The current Net Margin % is -1.92%. Level Bio AB's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Level Bio AB (FRA:4MB), the current Net Margin % is -1.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Level Bio AB Business Description

Other Exchanges LEVBIO:Sweden
Address Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
23GF Score

Get the complete analysis for FRA:4MB

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price